Sterling Capital Management
DNA icon

Sterling Capital Management’s Ginkgo Bioworks DNA Stock Holding History

Sterling Capital Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$12K Sell
939
-21
-2% -$171 ﹤0.01% 2434
2026
Q2 		$9.5K Sell
960
-406
-30% -$3.4K ﹤0.01% 2247
2026
Q1 		$8.37K Sell
1,366
-879
-39% -$7.31K ﹤0.01% 2474
2025
Q4 		$18.7K Sell
2,245
-271
-11% -$2.92K ﹤0.01% 2265
2025
Q3 		$36.7K Buy
2,516
+1,528
+155% +$18.3K ﹤0.01% 1874
2025
Q2 		$11.1K Buy
+988
New +$7.65K ﹤0.01% 2059

Other funds holding DNA

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Erste Asset Management
Erste Asset Management Vienna, Austria $13.7B AUM 40.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
J.M. Forbes & Co
J.M. Forbes & Co Boston, Massachusetts $1.33B AUM 21.14% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Sterling Capital Management's DNA Position: Q3 2026 in Review

Sterling Capital Management reduced its Ginkgo Bioworks (DNA) stake by 2.2% in Q3 2026, selling an estimated $171 and leaving 939 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #2434.

Sterling Capital Management first reported a position in DNA in Q2 2025 and has held it in 6 quarters since. The position peaked at $36.7K in Q3 2025. 128 funds tracked by Wall St. Rank hold DNA as of Q3 2026.

  • Sterling Capital Management held 939 shares of Ginkgo Bioworks worth $12K as of Q3 2026.
  • Sterling Capital Management sold 21 Ginkgo Bioworks shares in Q3 2026, an estimated $171.
  • Ginkgo Bioworks made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #2434 holding.
  • Sterling Capital Management first reported a position in Ginkgo Bioworks in Q2 2025 and has held it in 6 quarters since.
  • Sterling Capital Management's Ginkgo Bioworks position peaked at $36.7K in Q3 2025.
  • 128 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.

Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.